definiens: as used herein shall mean that [COMPANY] shall have the right to independently develop CAIV Products which do not incorporate the Master Donor Strains or any derivatives or reassortants thereof, but shall not have the right to manufacture for commercial sale or sell CAIV Products during the term of this Restated Agreement other than the Manufacture for [COMPANY] or its designee or W - A under this Restated Agreement . For the avoidance of doubt:-7.5.1.1 [COMPANY] shall not, for the term of this Restated Agreement, manufacture, in eggs, cell culture, or by other means, for itself or a third party any CAIV Product based on the Master Donor Strains, the Master Virus Seeds or any reassortants or derivatives thereof, and [COMPANY] shall not conduct any research or development activities using the Master Donor Strains, Master Virus Seeds, reassortants or derivatives thereof, which have not been not authorized in writing by [COMPANY], including but not limited to any replication of said in cell - based culture systems, but otherwise nothing in this Restated Agreement shall prevent [COMPANY] from manufacturing for a third party a CAIV Product ( other than any CAIV Product based on the Master Donor Strains, the Master Virus Seeds or any reassortants or derivatives thereof ) in circumstances where that third party provides to [COMPANY] complete technical information pertaining to the process of manufacture of the third party 's CAIV Product and [COMPANY] is not required to utilize [COMPANY] Process Technology to help develop or enhance the third party 's process of manufacture of its CAIV Product . ; and 7.5.1.2 [COMPANY] may utilize those aspects of the [COMPANY] Process Technology that are in the public domain to make, have made, use, import, offer for sale and sell products other than CAIV Products . If [COMPANY] is in any doubt as to whether or not a particular aspect of the [COMPANY] Process Technology is in the public domain, it shall provide to [COMPANY] a written request for guidance setting forth sufficient detail to allow [COMPANY] to make its decision and [COMPANY] shall, within twenty eight ( 28 ) days of receipt of such written request, provide to [COMPANY] an answer to its question ; provided, that if the parties disagree whether or not a particular aspect of [COMPANY] Process Technology is in the public domain, the matter shall be submitted for expert opinion in accordance with Schedule 14 . Thereafter, if there is still a dispute between the parties as to whether or not a particular aspect of [COMPANY] Process Technology is in the public domain, the matter shall be referred to the respective Chief Executive Officers of the parties and, thereafter, if the matter is still unresolved, either party may issue proceeding to have the matter determined by a court of law in accordance with clause 21.5 ; and [ ) = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED